Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.64 |
| ▸ | NCF1 | P14598 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 2/20 | 0.50 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.50 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | FERMT2 | Q96AC1 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30200129 | 1.00 | LOXL2 (0.64) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| Bromide SCHEMBL15618161 | 0.98 | LOXL2 (0.62) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| Hydrochloric Acid SCHEMBL8762058 | 0.98 | LOXL2 (0.62) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| Benzene SCHEMBL6631416 | 0.98 | LOXL2 (0.62) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| SCHEMBL1282250 | 0.85 | MAPT (0.54) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| SCHEMBL27751565 | 0.83 | LOXL2 (0.60) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| Hydrochloric Acid SCHEMBL16752130 | 0.83 | MAPT (0.52) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| SCHEMBL334360 | 0.80 | LOXL2 (0.67) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| SCHEMBL31599195 | 0.80 | LOXL2 (0.67) | LOXL2NCF1HTR1AADRA1DADRA1A | |
| Bromide SCHEMBL9399386 | 0.78 | LOXL2 (0.64) | LOXL2NCF1HTR1AADRA1DADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116396260-A | Genipin ether with uric acid reducing and kidney protecting functions, and preparation method and application thereof | 山东省农业科学院 | 2023-07-07 | — | — | CN | claimed |
| EP-2948437-B1 | APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC (US) | 2021-11-03 | — | — | EP | claimed |
| CN-110003159-A | Synthesize the new method of catechin | 斯法尔制药私人有限公司 | 2019-07-12 | — | — | CN | claimed |
| EP-2668176-B1 | A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PTE LTD (SG) | 2017-05-17 | — | — | EP | claimed |
| US-9556140-B2 | Approach for synthesis of catechins | SPHAERA PHARMA PVT. LTD. (IN) | 2017-01-31 | — | — | US | claimed |
| US-9428482-B2 | Process for synthesis of polyphenols | SPHAERA PHARMA PTE. LTD. (SG) | 2016-08-30 | — | — | US | claimed |
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC. | 2015-12-24 | — | — | US | claimed |
| EP-2948437-A2 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | Sphaera Pharma Pvt. Ltd. (IN) | 2015-12-02 | — | — | EP | claimed |
| CN-105026384-A | Novel method for synthesizing catechin | SPHAERA PHARMA PRIVATE LTD | 2015-11-04 | — | — | CN | claimed |
| WO-2014115174-A2 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | SPHAERA PHARMA PVT. LTD. (IN) | 2014-07-31 | — | — | WO | claimed |
| EP-1291353-A1 | 6-O-substituted ketolides having antibacterial activity | ABBOTT LABORATORIES (US) | 2003-03-12 | — | — | EP | claimed |
| EP-1007530-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 2000-06-14 | — | — | EP | claimed |
| US-6028181-A | 6-0-Substituted antibacterial erythromycin ketolides and methods of making | ABBOTT LABORATORIES (US) | 2000-02-22 | — | — | US | claimed |
| CN-1237183-A | 6-0-substituted ketolides with antibacterial activity | ABBOTT CO (US) | 1999-12-01 | — | — | CN | claimed |
| CN-1224427-A | 6-O-substituted erythromycin compounds and preparation method thereof | ABBOTT LAB (US) | 1999-07-28 | — | — | CN | claimed |
| EP-0929563-A1 | 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | Abbott Laboratories (US) | 1999-07-21 | — | — | EP | claimed |
| EP-0918783-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1998009978-A1 | 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY | ABBOTT LABORATORIES (US) | 1998-03-12 | — | — | WO | claimed |
| WO-1997042204-A1 | 6-O-SUBSTITUTED ERYTHROMYCINS AND METHOD FOR MAKING THEM | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997042206-A1 | 6-O-SUBSTITUTED ERYTHROMYCIN COMPOUNDS AND METHOD FOR MAKING SAME | ABBOTT LABORATORIES (US) | 1997-11-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | NQO1, COMT, NNMT | LOXL2 4217/4885NCF1 1807/4885HTR1A 1118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.